Cardiac Myofilament Calcium Sensitizer Pimobendan for Preclinical Mmvd Stage B2 in Dogs

Cardiac Myofilament Calcium Sensitizer Pimobendan for Preclinical Mmvd Stage B2 in Dogs. Delays Heart Failure Onset: Significantly delays clinical signs of congestive heart failure in preclinical MMVD Stage B2 dogs by approx. 15 months. Extends Survival Time: Effective in improving clinical signs and extending survival time in dogs with dilated cardiomyopathy or valvular insufficiency. Dual Mechanism of Action: Enhances calcium sensitivity of cardiac myofilaments and selectively inhibits phosphodiesterase III for vasodilation. High Palatability: Beef-flavored chewable tablets with a bisecting score line, designed for easy administration and good taste. OEM/ODM Customization: Supports customization from samples and designs, with OEM and ODM services available for tailored solutions. 100% Quality Inspection: Finished products undergo 100% visual and function inspection to ensure consistent quality and safety standards. Fast Lead Time: Average lead time within 15 workdays for both peak and off-season periods, ensuring timely supply.